Tanshinone, a Natural NADPH Oxidase Inhibitor, Mitigates Testosterone-Induced Hair Loss

Yeo Kyu Hur1, Jin Yeong Chae1, Min Hye Choi1

  • 1Department of Life Sciences, Ewha Womans University, Seoul 03760, Republic of Korea.

PubMed

Insights

Testosterone causes hair loss by increasing oxidative stress. Tanshinone compounds from Salviae Miltiorrhizae Radix inhibit this process, showing potential for treating androgenetic alopecia (AGA).

Area of Science:

  • Dermatology
  • Molecular Biology
  • Pharmacology

Background:

  • Androgenetic alopecia (AGA) is linked to testosterone-induced keratinocyte apoptosis via the GPRC6A-Duox1 axis and hydrogen peroxide (H₂O₂) production.
  • Understanding the non-genomic regulation of cellular redox status in AGA is crucial for developing targeted therapies.

Purpose of the Study:

  • To elucidate the molecular mechanism of testosterone's effect on cellular redox status in AGA.
  • To identify natural compounds that inhibit Nox enzymes, key mediators of oxidative stress in AGA.

Main Methods:

  • High-throughput screening of natural compounds for Nox inhibitory activity.
  • In vitro assays to determine IC₅₀ values of identified compounds against Nox isozymes.
  • 3D computational docking analysis to elucidate the inhibition mechanism.
  • In vivo animal studies using testosterone-induced hair loss model in C57BL/6J mice.

Main Results:

  • Diterpenoid compounds (Tanshinone I, IIA, IIB, Cryptotanshinone) from Salviae Miltiorrhizae Radix were identified as potent Nox inhibitors.
  • Tanshinone compounds bind to the NADPH/FAD site, inhibiting Nox activity and reducing testosterone-induced H₂O₂ production and keratinocyte apoptosis.
  • Tanshinone I and IIA treatment in mice significantly promoted hair regrowth in a testosterone-induced hair loss model.

Conclusions:

  • Tanshinone I and Tanshinone IIA effectively inhibit the testosterone-activated Nox pathway implicated in AGA.
  • These findings highlight the therapeutic potential of Tanshinone I and IIA for treating androgenetic alopecia by targeting Nox activity.